Feasibility study of microbial ecosystem therapeutics (MET-4) to evaluate effects of fecal microbiome in patients on immunotherapy (MET4-IO). This is an ASCO Meeting Abstract from the 2019 ASCO Annual ...
It was recently reported that a PPARα/γ agonist elevated pyruvate dehydrogenase kinase isozyme 4 (PDK4) mRNA levels in liver compared with vehicle or a PPARγ agonist [42]. In the present study, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results